Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$4.02M Sell
300,398
-56,142
-16% -$816K ﹤0.01% 2239
2014
Q2
$5.18M Buy
356,540
+116,090
+48% +$1.7M ﹤0.01% 1933
2014
Q1
$3.79M Buy
240,450
+52,714
+28% +$841K ﹤0.01% 2132
2013
Q4
$3.1M Buy
187,736
+60,488
+48% +$886K ﹤0.01% 2363
2013
Q3
$1.63M Sell
127,248
-49,404
-28% -$586K ﹤0.01% 2815
2013
Q2
$2.04M Buy
+176,652
New +$1.99M ﹤0.01% 2535

Other funds holding GNTX

UBS's GNTX Position: Q3 2014 in Review

UBS reduced its Gentex (GNTX) stake by 16% in Q3 2014, selling an estimated $816K and leaving 300,398 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

UBS first reported a position in GNTX in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.18M in Q2 2014. 319 funds tracked by Wall St. Rank hold GNTX as of Q3 2014.

  • UBS held 300,398 shares of Gentex worth $4.02M as of Q3 2014.
  • UBS sold 56,142 Gentex shares in Q3 2014, an estimated $816K.
  • Gentex made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2239 holding.
  • UBS first reported a position in Gentex in Q2 2013 and has held it in 6 quarters since.
  • UBS's Gentex position peaked at $5.18M in Q2 2014.
  • 319 funds tracked by Wall St. Rank held Gentex as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.